What You Are Up Against When Devising A Treatment Plan For Syphilis
If you are a clinician and you are planning on designing a syphilis treatment plan, expect to be up against some challenges. It is a microorganism that causes the condition known as syphilis, and it is called spirochete bacterium. This has led many to believe that if they want to treat syphilis, they could do so easily and with zero complications. But it is actually complicated. Do not expect to have an easy time of designing a treatment plan for syphilis. As early as the diagnosis stage, you will find many challenges and obstacles in place, making your road that much trickier. That is because the presentations of syphilis is quite roundabout. There is no short cuts with it. Making the right diagnosis is quite complicated, causing clinicians to sweat a bit first. True, the microbiological tests that are carried out to diagnose this disease are straightforward enough. But you (as a clinician) have to first suspect the disease, in order to be in a position to order those particular microbiological tests. That's where things become tricky. It is hard to suspect the existence of syphilis just by looking at the symptoms alone. Once the correct diagnosis has been made, the challenge now lies in the design of the treatment plan. That is what we will tackle.
The first key challenge that you are likely to encounter, when designing a syphilis treatment plan, is that of figuring out how advanced the disease is, in each patient you have to treat. Let us say that you have patients in a more advanced stage and other patients that are in the earlier and more simple stages. You cannot expect the same treatment to work for them in the same way. Penicillin, administered through the intramuscular route in a single dose, is often adequate treatment for an uncomplicated case of this disease. That might not work for the advanced cases, though. Intravenous routes would have to be taken, and a single dose would not be enough. Often, it takes as much as 10 days for the whole treatment. The challenge for the clinician is to differentiate the uncomplicated cases to be treated through a single intramuscular dose, and the complicated cases to be treated through multiple intravenous doses. It is quite difficult to distinguish the complicated ones from the straightforward ones, though, and that gives a lot of grief to clinicians.
It is also likely that the syphilis has already done quite a number on the patient. The clinician would find it challenging to find some way to ensure that the damage or the effects could be treated or even reversed. The medications that are available (antibiotics) are very good in terms of curbing the disease's progression. Unfortunately, they do not treat the effects that have already taken place or fix the problems that already arose. And yet it is the desire of these patients to fix these problems too.
The third key challenge that you are likely to encounter, when designing a syphilis treatment plan, is that of figuring out (in advance) how patients are likely to respond to the various treatment courses. It can, for instance, be very hard to figure out if certain patients are likely to be allergic to medications like penicillin. Of course, you'd have to come up with alternative courses of action when treating the patients, and that is another challenge to add to the list.
About the Author
Obtain further advice on by visiting http://www.biogetica.com.
Tell others about
this page:
Comments? Questions? Email Here